Found 52 matching trials
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) PHASE3 The primary objective of the study is to compare sacituzumab tirumotecan co...
Show More Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma N/A To provide elotuzumab treatment for single-patient use....
Status
No Longer Available
Location
Icahn School.of Medicine at Mount Sinai
Learn More & Join Trial
Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study PHASE2 An open-label, single institutional phase II trial of losartan in patients ...
Show More Location
Oslo University Hospital
Learn More & Join Trial
Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma PHASE3 The incorporation of proteasome inhibitors and immunomodulatory drugs into ...
Show More Status
Active Not Recruiting
Location
Saint Antoine Hospital - Hematology Department
Learn More & Join Trial
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy PHASE2 This study is being conducted in patients with newly diagnosed breast cance...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults PHASE1 Transplant rejection occurs when a patient's body does not recognize the ne...
Show More Location
University of Wisconsin - Department of Medicine
Learn More & Join Trial
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data PHASE3 This REMAP Periop ERP domain study falls under the Periop Core Protocol, wh...
Show More Location
UPMC Magee-Womens Hospital
Learn More & Join Trial
Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma PHASE1 The goal of this clinical trial is to find out how well a combination of tw...
Show More Location
National University Hospital (NUH)
Learn More & Join Trial
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma PHASE2 The primary purpose of this study is to assess the efficacy (overall respon...
Show More Location
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058
Learn More & Join Trial